-
-
-
-
-
-
-
Truist Securities Upgrades Biogen (BIIB) to Buy
-
-
-
-
-
-
-
Biogen (BIIB) PT Raised to $225 at Piper Sandler
-
-
-
-
-
-
-
Stifel on Biogen (BIIB): 'We want to be a little cautious here until we see the full data'
-
-
-
-
-
-
-
Biogen (BIIB) PT Raised to $196 at Wedbush
-
-
-
-
-
-
-
Biogen (BIIB) PT Raised to $200 at BofA Securities
-
-
-
-
-
-
-
Biogen (BIIB) PT Raised to $245 at Canaccord
-
-
-
-
-
-
-
BMO Capital on Biogen (BIIB): Apellis deal 'sets a clear path for further expansion in nephrology'
-
432,154 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

